Cargando…

Genomic features of Chinese small cell lung cancer

BACKGROUND: Small cell lung cancer (SCLC) is an aggressive disease with poor survival. Although molecular and clinical characteristics have been established for SCLC in western patients, limited investigation has been performed for Chinese SCLC patients. OBJECTIVE: In this study, we investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jun, Zhao, Zhuxiang, Wei, Shuquan, Li, Binkai, Zhao, Ziwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123817/ https://www.ncbi.nlm.nih.gov/pubmed/35596192 http://dx.doi.org/10.1186/s12920-022-01255-3

Ejemplares similares

LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis
por: Wei, Shuquan, et al.
Publicado: (2019)

Two CHRN susceptibility variants for COPD are genetic determinants of emphysema and chest computed tomography manifestations in Chinese patients
por: Zhao, Zhuxiang, et al.
Publicado: (2017)

In vitro synergistic effect of amlodipine and imipenem on the expression of the AdeABC efflux pump in multidrug-resistant Acinetobacter baumannii
por: Hu, Chao, et al.
Publicado: (2018)

Immunogenicity of small‐cell lung cancer associates with STING pathway activation and is enhanced by ATR and TOP1 inhibition
por: Li, Xuetao, et al.
Publicado: (2022)

Genomic correlates of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients
por: Li, Kang, et al.
Publicado: (2022)

Sex-biased molecular differences in lung adenocarcinoma are ethnic and smoking specific
por: Li, Xuetao, et al.
Publicado: (2023)

Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer
por: Li, Yue, et al.
Publicado: (2022)

Lung Features in Individuals with Biomass Smoke Exposure Characterized by CT Scan and Changes in Pulmonary Function
por: Chen, Jinglong, et al.
Publicado: (2021)

Tumor Mutational Burden and Genomic Alterations in Chinese Small Cell Lung Cancer Measured by Whole-Exome Sequencing
por: Su, Shan, et al.
Publicado: (2019)

A nomogram based on A-to-I RNA editing predicting overall survival of patients with lung squamous carcinoma
por: Liu, Li, et al.
Publicado: (2022)

HER2 mutations in Chinese patients with non-small cell lung cancer
por: Song, Zhengbo, et al.
Publicado: (2016)

Molecular subtyping of small‐cell lung cancer based on mutational signatures with different genomic features and therapeutic strategies
por: Wang, Haiyong, et al.
Publicado: (2022)

Clinical and genomic features of non‐small cell lung cancer occurring in families
por: Miyabe, Shingo, et al.
Publicado: (2023)

Clinical features and prognosis according to genomic mutations in primary and metastatic lesions of non‐small‐cell lung cancer
por: Zhang, Wei, et al.
Publicado: (2022)

Clinical and genomic features of Chinese lung cancer patients with germline mutations
por: Peng, Wenying, et al.
Publicado: (2022)

The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients
por: Lin, Quan, et al.
Publicado: (2019)

Genomic characteristics of driver genes in Chinese patients with non‐small cell lung cancer
por: Si, Xiaoyan, et al.
Publicado: (2020)

Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients
por: Zhang, Xu-Chao, et al.
Publicado: (2019)

Efficacy and Safety of Endoscopic Tympanic Membrane Catheterization Plus Ofloxacin Ear Drops in the Treatment of Secretory Otitis Media in Infants and Toddlers
por: Zhao, Zhang, et al.
Publicado: (2022)

The clinicopathological and prognostic features of Chinese and Japanese inpatients with lung cancer
por: Gao, Yang, et al.
Publicado: (2016)

The genomic characteristics of RET fusion positive tumors in Chinese non-small cell lung cancer (NSCLC) patients
por: Wu, Guowu, et al.
Publicado: (2022)

Population pharmacokinetics and individualized lobaplatin regimen for the treatment of Chinese small cell lung cancer in the elderly
por: Cheng, Ying, et al.
Publicado: (2019)

The lncRNA HOTAIR regulates autophagy and affects lipopolysaccharide‐induced acute lung injury through the miR‐17‐5p/ATG2/ATG7/ATG16 axis
por: Li, Yujun, et al.
Publicado: (2021)

Genomic characteristics in Chinese non-small cell lung cancer patients and its value in prediction of postoperative prognosis
por: Zhang, Bin, et al.
Publicado: (2020)

Correlation among genetic variations of c-MET in Chinese patients with non-small cell lung cancer
por: Duan, Jianchun, et al.
Publicado: (2017)

Comparative study on the mutation spectrum of tissue DNA and blood ctDNA in patients with non-small cell lung cancer
por: Zhang, Meichun, et al.
Publicado: (2022)

Distribution and Drug Resistance of Bacterial Infection in Hospitalized Patients at the Respiratory Department before and after the COVID-19 Pandemic in Guangzhou, China
por: Hao, Ling, et al.
Publicado: (2023)

Clinicopathologic characteristics and outcomes of Chinese patients with non‐small‐cell lung cancer and BRAF mutation
por: Ding, Xi, et al.
Publicado: (2017)

Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
por: Hellmann, Matthew D., et al.
Publicado: (2018)

Comprehensive genomic profiling of small cell lung cancer in Chinese patients and the implications for therapeutic potential
por: Hu, Jing, et al.
Publicado: (2019)

TERT Mutations in Non–Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Implications
por: Yang, Liu, et al.
Publicado: (2023)

The potential of high-order features of routine blood test in predicting the prognosis of non-small cell lung cancer
por: Luo, Liping, et al.
Publicado: (2023)

Whole exome analysis reveals the genomic profiling related to chemo‐resistance in Chinese population with limited‐disease small cell lung cancer
por: Yu, Jiangyong, et al.
Publicado: (2022)

Molecular Characteristics and Quantitative Proteomic Analysis of Klebsiella pneumoniae Strains with Carbapenem and Colistin Resistance
por: Hao, Ling, et al.
Publicado: (2022)

Clinicopathologic characteristics and diagnostic methods of RET rearrangement in Chinese non-small cell lung cancer patients
por: Feng, Junnan, et al.
Publicado: (2022)

Lung microbiota features of stage III and IV non-small cell lung cancer patients without lung infection
por: Zhang, Miao, et al.
Publicado: (2022)

Practice Patterns of Treatment Strategy of Limited-Stage Small-Cell Lung Cancer: Survey of Chinese Oncologists
por: Xu, Chang, et al.
Publicado: (2022)

Crizotinib in Chinese Patients with ROS1-Rearranged Advanced Non‒Small-Cell Lung Cancer in Routine Clinical Practice
por: Liu, Chang, et al.
Publicado: (2019)

Three models that predict the efficacy of immunotherapy in Chinese patients with advanced non‐small cell lung cancer
por: Zhao, Qian, et al.
Publicado: (2021)

Circular RNA circ-ABCB10 Promotes Proliferation and Inhibits Apoptosis of Laryngeal Carcinoma by Inhibiting KLF6
por: Chen, Zhuxiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_315mucbfeo364fuo8eikk9gard